References
- Alig L, Edenhofer A, Hadváry P, Hurzeler M, Knopp D, Muller M, Steiner B, Trzeciak A, Weller T. Low molecular weight, non-peptide fibrinogen receptor antagonists. J Med Chem 1992; 35: 4393–4407
- Coller B S. Platelets and thrombolytic therapy. N Engl J Med 1990; 322: 33–42
- Coller B S. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest 1985; 76: 101–108
- Ginsberg M H, Loftus J C, Plow E F. Cytoadhesins, integrins and platelets. Thromb Haemost 1988; 59: 1–6
- Gould R J, Polokoff M A, Friedman P A, Huang T, Holt J C, Cook J J, Niewiarowski S. Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 1990; 195: 168–171
- Jordan R E, Knight D M, Wagner C, McAleer M F, McDonough M, Mattis J A, Coller B S, Weisman H F, Ghrayeb J. A dramatic reduction of the immunogenicity of the anti-GPIIb/IIIa monoclonal antibody, 7E3 Fab, by humanization of the murine constant domains. Circulation 1992; 86: I-410
- Kekomaki R, Kauppinen H L, Penttinen K, Myllylä G. Interaction of immune complexes and platelets in rabbits immunized with hapten-carrier conjugates. Acta Pathol Microbiol Scand Sect C 1977; 86: 207–214
- Larsson A, Egberg N, Lindahl T L. Platelet activation and binding of complement components to platelets induced by immune complexes. Platelets 1994; 5: 149–155
- Larsson A, Nilsson B, Lindahl T L, Frödin L, Wahlberg J. Immune complex induced thrombocytopenia after in vivo treatment with horse anti-lymphocyte antibodies. Thromb Haemorr Dis 1994; 8: 53–56
- Larsson A, Wejåker P E, Forsberg P O, Lindahl T L. Chicken antibodies: A tool to avoid interference by complement activation in ELISA. J Immunol Methods 1992; 156: 79–83
- Lindahl T L, Festin R, Larsson A. Studies of fibrinogen binding to platelets by flow cytometry: An improved method for detection of platelet activation. Thromb Haemostas 1992; 68: 221–225
- Lindahl T L, Larsson A. C1q binding to platelets induced by monoclonal antibodies and immune complexes- A flow cytometric analysis. Platelets 1993; 4: 73–77
- Phillips D R, Charo I F, Parise L V, Fitzgerald L A. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831–843
- Seymour J L, Henzel W J, Nevins B, Stults J T, Lazarus R A. Decorsin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella Decora. J Biol Chem 1990; 265: 10143–10147
- Shattil S J, Cunningham M, Hoxie J A. Detection of activated platelets in whole blood using activation dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307–315
- Shattil S J, Hoxie J A, Cunningham M, Brass L F. Changes in platelet membrane glycoprotein IIb/IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107–14
- Steiner B, Cousot D, Trzeciak A, Gillessen D, Hadváry P. Ca2+-dependent binding of a synthetic arg-gly-asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb/IIIa complex. J Biol Chem 1989; 264: 13102–13108
- Theofilopoulos A N, Dixon F J. Immune complexes in human diseases. Am J Pathol 1980; 100: 530–591
- Topol E J, Plow E F. Clinical trials of platelet receptor inhibitors. Thromb Haemost 1993; 70: 94–98
- Yuan A S, Hand E L, Hichens M, Olah T V, Barrish A, Fernandez-Metzler C, Gilbert J D. Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay. J Pharm Biomed Anal 1993; 11: 427–434